SCHEMBL8306324

SCHEMBL8306324

CC#Cc1ccc(O)c(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.48
CA1 P00915 2/20 0.48
TSHR P16473 2/20 0.46
HSD17B10 Q99714 2/20 0.46
ESR2 Q92731 3/20 0.39
CYP1A1 P04798 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP1B1 Q16678 2/20 0.39
ESR1 P03372 2/20 0.36
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36
HPGD P15428 1/20 0.36
AR P10275 1/20 0.36
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
ALDH1A1 P00352 1/20 0.34
HNF4A P41235 1/20 0.34
PYGL P06737 1/20 0.33
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3817229 0.80 PYGL (0.43) TSHRHSD17B10CYP1A1CYP1A2CYP1B1
SCHEMBL8772370 0.77 CYP3A4 (0.50) HSD17B10CYP1A1CYP1A2CYP1B1HPGD
SCHEMBL5671970 0.76 APP (0.59) CA2CA1TSHRHSD17B10HSP90AA1
SCHEMBL25026499 0.75 CYP3A4 (0.46) CA2CA1TSHRHSD17B10ESR2
SCHEMBL8772088 0.75 CYP1A1 (0.39) TSHRCYP1A1CYP1A2CYP1B1ALDH1A1
SCHEMBL8772677 0.75 CYP1A1 (0.40) CYP1A1CYP1A2CYP1B1PYGL
SCHEMBL407449 0.74 TSHR (0.50) CA2CA1TSHRHSD17B10ESR2
SCHEMBL7160560 0.74 HSD17B10 (0.50) CA2CA1TSHRHSD17B10ESR2
SCHEMBL8306218 0.74 TSHR (0.50) CA2CA1TSHRHSD17B10ESR2
SCHEMBL8865572 0.73 ALDH1A1 (0.44) HSD17B10CYP1A2HPGDARALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004072243-A2 MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2004-08-26 WO disclosed